These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5798470)

  • 1. Effects of a cardio-selective beta-adrenergic blocker (I.C.I. 50172) at exercise in angina pectoris.
    Areskog NH; Adolfsson L
    Br Med J; 1969 Jun; 2(5657):601-3. PubMed ID: 5798470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
    Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
    Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
    Coltart DJ; Hamer J
    Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of propranolol (inderal) on exercise tolerance in angina pectoris.
    Hamer J; Grandjean T; Melendez L; Sowton GE
    Br Heart J; 1966 May; 28(3):414-8. PubMed ID: 5327848
    [No Abstract]   [Full Text] [Related]  

  • 13. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 14. Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
    Talbot S
    Cardiology; 1976; 61(4):254-66. PubMed ID: 13931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECT OF A BETA-ANDRENERGIC-BLOCKING AGENT (NETHALIDE) AND NITROGLYCERIN ON EXERCISE TOLERANCE IN ANGINA PECTORIS.
    MACALPIN RN; KATTUS AA; WINFIELD ME
    Circulation; 1965 Jun; 31():869-75. PubMed ID: 14297521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic changes during practolol administration under various stress conditions in angina pectoris].
    Stauch M; Härich BK; Schäfer N
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():176-9. PubMed ID: 5140980
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta adrenergic blocking drugs as treatment for angina pectoris.
    Dornhorst AC
    Ann N Y Acad Sci; 1967 Feb; 139(3):968-70. PubMed ID: 5232350
    [No Abstract]   [Full Text] [Related]  

  • 19. NONSPECIFIC AND BETA-ADRENERGIC BLOCKING EFFECTS OF ALDERLIN IN ANGINA PECTORIS.
    STRAIT GB; BRUCE RA
    Am Heart J; 1965 Aug; 70():150-6. PubMed ID: 14327998
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study.
    Sealey BJ; Liljedal J; Nyberg G; Ablad B
    Br Heart J; 1971 Jul; 33(4):481-8. PubMed ID: 4397626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.